Back to Search
Start Over
Replacement Myocardial Fibrosis in Patients With Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling, and Arrhythmia
- Source :
- Circulation, Circulation, American Heart Association, 2021, 143 (18), pp.1763-1774. ⟨10.1161/CIRCULATIONAHA.120.050214⟩
- Publication Year :
- 2021
- Publisher :
- HAL CCSD, 2021.
-
Abstract
- Background: Mitral valve prolapse (MVP) is a frequent disease that can be complicated by mitral regurgitation (MR), heart failure, arterial embolism, rhythm disorders, and death. Left ventricular (LV) replacement myocardial fibrosis, a marker of maladaptive remodeling, has been described in patients with MVP, but the implications of this finding remain scarcely explored. We aimed at assessing the prevalence, pathophysiological and prognostic significance of LV replacement myocardial fibrosis through late gadolinium enhancement (LGE) by cardiac magnetic resonance in patients with MVP. Methods: Four hundred patients (53±15 years of age, 55% male) with MVP (trace to severe MR by echocardiography) from 2 centers, who underwent a comprehensive echocardiography and LGE cardiac magnetic resonance, were included. Correlates of replacement myocardial fibrosis (LGE+), influence of MR degree, and ventricular arrhythmia were assessed. The primary outcome was a composite of cardiovascular events (cardiac death, heart failure, new-onset atrial fibrillation, arterial embolism, and life-threatening ventricular arrhythmia). Results: Replacement myocardial fibrosis (LGE+) was observed in 110 patients (28%; 91 with myocardial wall including 71 with basal inferolateral wall, 29 with papillary muscle). LGE+ prevalence was 13% in trace-mild MR, 28% in moderate MR, and 37% in severe MR, and was associated with specific features of mitral valve apparatus, more dilated LV and more frequent ventricular arrhythmias (45% versus 26%, P P =0.009) and moderate-severe MR (odds ratio, 2.28 [95% CI, 1.21–4.31], P =0.011). LGE+ was associated with worse 4-year cardiovascular event–free survival (49.6±11.7 in LGE+ versus 73.3±6.5% in LGE–, P P =0.002) were associated with poor outcome. Conclusions: LV replacement myocardial fibrosis is frequent in patients with MVP; is associated with mitral valve apparatus alteration, more dilated LV, MR grade, and ventricular arrhythmia; and is independently associated with cardiovascular events. These findings suggest an MVP-related myocardial disease. Last, cardiac magnetic resonance provides additional information to echocardiography in MVP.
- Subjects :
- Male
medicine.medical_specialty
Arterial embolism
[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Fibrosis
Physiology (medical)
Internal medicine
medicine
[INFO.INFO-IM]Computer Science [cs]/Medical Imaging
Mitral valve prolapse
Humans
In patient
030212 general & internal medicine
cardiovascular diseases
Ventricular remodeling
Mitral regurgitation
Mitral Valve Prolapse
Ventricular Remodeling
business.industry
Myocardium
Mitral Valve Insufficiency
Arrhythmias, Cardiac
Middle Aged
medicine.disease
3. Good health
Echocardiography
Heart failure
Cardiology
cardiovascular system
Myocardial fibrosis
Female
Cardiology and Cardiovascular Medicine
business
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Subjects
Details
- Language :
- English
- ISSN :
- 00097322 and 15244539
- Database :
- OpenAIRE
- Journal :
- Circulation, Circulation, American Heart Association, 2021, 143 (18), pp.1763-1774. ⟨10.1161/CIRCULATIONAHA.120.050214⟩
- Accession number :
- edsair.doi.dedup.....6da9c5a04ae572f0a310343e81616be8
- Full Text :
- https://doi.org/10.1161/CIRCULATIONAHA.120.050214⟩